Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
Authors
Keywords
Nasopharyngeal carcinoma, Epstein-Barr virus DNA, Clinical trial, Survival, Recursive partitioning analysis
Journal
RADIOTHERAPY AND ONCOLOGY
Volume 167, Issue -, Pages 179-186
Publisher
Elsevier BV
Online
2021-12-28
DOI
10.1016/j.radonc.2021.12.029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy
- (2021) Zhaodong Fei et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
- (2019) Wen-Fei Li et al. INTERNATIONAL JOURNAL OF CANCER
- Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy
- (2019) Quynh Thu Le et al. JNCI-Journal of the National Cancer Institute
- The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012
- (2019) Xue-Song Sun et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
- (2019) Jiawei Lv et al. Nature Communications
- Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
- (2019) Cheng Xu et al. Frontiers in Oncology
- Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
- (2018) R L Hong et al. ANNALS OF ONCOLOGY
- Ambient Temperature and Screening for Nasopharyngeal Cancer
- (2018) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
- (2018) Jian Zhang et al. BMC CANCER
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
- (2017) Su-Mei Cao et al. EUROPEAN JOURNAL OF CANCER
- Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer
- (2017) Kelly Y. Kim et al. JNCI-Journal of the National Cancer Institute
- Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era
- (2017) Ling-Long Tang et al. Journal of the National Comprehensive Cancer Network
- Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center
- (2017) Li-Rong Wu et al. ORAL ONCOLOGY
- PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma
- (2017) Feng Liu et al. Radiation Oncology
- Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study
- (2017) Xiao-Wen Lan et al. OncoTargets and Therapy
- Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer
- (2017) Kelly Y. Kim et al. JNCI-Journal of the National Cancer Institute
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
- (2015) Terence Tan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Clinical Utility of Plasma Epstein–Barr Virus DNA Assays in Nasopharyngeal Carcinoma
- (2015) Wenna Zhang et al. MEDICINE
- Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
- (2014) S. F. Leung et al. ANNALS OF ONCOLOGY
- Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
- (2011) G. Fountzilas et al. ANNALS OF ONCOLOGY
- Hypofractionated Dose-Painting Intensity Modulated Radiation Therapy With Chemotherapy for Nasopharyngeal Carcinoma: A Prospective Trial
- (2010) Richard L. Bakst et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China
- (2008) Yong Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
- (2008) Edwin P. Hui et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started